What is the recommended dose of Cefdinir (Cefdinir) in patients with End-Stage Renal Disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

Patients With Renal Insufficiency For adult patients with creatinine clearance <30 mL/min, the dose of cefdinir should be 300 mg given once daily. In patients maintained on chronic hemodialysis, the recommended initial dosage regimen is a 300 mg or 7 mg/kg dose every other day. For pediatric patients with a creatinine clearance of <30 mL/min/1. 73 m2, the dose of cefdinir should be 7 mg/kg (up to 300 mg) given once daily.

The dose of cefdinir in patients with End-Stage Renal Disease (ESRD) is 300 mg given once daily for adults, and 7 mg/kg (up to 300 mg) given once daily for pediatric patients. For patients on hemodialysis, the recommended dose is 300 mg or 7 mg/kg every other day, with an additional dose given at the conclusion of each hemodialysis session 1.

From the Research

For patients with end-stage renal disease (ESRD), the recommended cefdinir dosage is 300 mg once daily or 7 mg/kg once daily for pediatric patients, which is a 50% reduction from the standard dose used in patients with normal renal function, as supported by general medical knowledge and dosing guidelines for renal impairment 2, 3. The dosage reduction is necessary because impaired renal function leads to decreased drug clearance and potential accumulation of the medication, which could increase the risk of adverse effects such as nausea, diarrhea, and headache.

  • Key considerations for cefdinir dosing in ESRD patients include:
    • Administering the dose after dialysis sessions for patients on hemodialysis, as cefdinir is partially removed during hemodialysis 4
    • Monitoring patients for clinical response and signs of toxicity
    • Maintaining the frequency of once daily for severe infections, rather than increasing the individual dose, to avoid drug accumulation while maintaining therapeutic efficacy It's also important to note that nonrenal clearance pathways may be altered in patients with ESRD, which can impact drug metabolism and transport 5, 6. However, the specific effects of these changes on cefdinir dosing are not well established, and therefore, the recommended dosage is based on general guidelines for renal impairment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.